Bárbara Osmarin Turra
Research Subjects
Research Interests
Bárbara Osmarin Turra has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Fernanda Barbisan
Universidade Federal de Santa Maria
3 shared publications - Ivana Beatrice Mânica da Cruz
Universidade Federal de Santa Maria
3 shared publications - Cristina Maranghello
Centro de Ensino, Pesquisa e Desenvolvimento Tecnológico GERONTEC, Fundação Universidade Aberta da Terceira Idade, FUnATI, Manaus 69029-040, AM, Brazil
2 shared publications - Douglas Reis Siqueira
Research, Teaching and Technological Development Center, Fundação Universidade Aberta da Terceira Idade, Manaus 69029-040, Brazil
2 shared publications - Ednea Aguiar Maia Ribeiro
Research, Teaching and Technological Development Center, Fundação Universidade Aberta da Terceira Idade, Manaus 69029-040, Brazil
2 shared publications - Erickson Oliveira dos Santos
Research Laboratory for Water Reuse, Samsung Research & Development Institute Brazil, Samsung Eletrônica da Amazônia, Manaus 69075-842, Brazil
2 shared publications
Latest Publications
- Open Access
- 15 March 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (3) , 348
Synergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson’s Disease Management
Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder linked to oxidative stress, mitochondrial dysfunction, and neuroinflammation. This study evaluates the neurofunctional and immunomodulatory effects of an aqueous extract combining cocoa seed husk and guarana powder (GuaCa). Eighteen extracts were characterized by flavonoid and polyphenol content, antioxidant activity, and genoprotective potential. The HCE3 extract, rich in catechins, quercetin, and epigallocatechin gallate, was selected for further analysis in three models: Eisenia fetida earthworms, SH-SY5Y neuron-like cells, and peripheral blood mononuclear cells (PBMCs) from PD patients. Results: The extracts showed antioxidant and genoprotective activity and contained flavonoid. No significant toxicity was observed in Eisenia fetida. In SH-SY5Y cells, GuaCa increased cell viability and brain-derived neurotrophic factor (BDNF) levels and reduced mitochondrial damage by lowering extracellular NDUSF7 (subunit of the NADH dehydrogenase (ubiquinone) complex) levels. In dPD-PBMCs cultures, GuaCa reduced pro-inflammatory cytokine IL-6 levels, indicating immunomodulatory effects. Conclusion: GuaCa shows promise as a nutraceutical for managing neuroinflammation and mitochondrial dysfunction in PD. Further clinical studies are needed to confirm GuaCa extract efficacy and potential for neuroprotective dietary strategies.
- 15 March 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (3) , 348
Open AccessSynergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson’s Disease Management
Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder linked to oxidative stress, mitochondrial dysfunction, and neuroinflammation. This study evaluates the neurofunctional and immunomodulatory effects of an aqueous extract combining cocoa seed husk and guarana powder (GuaCa). Eighteen extracts were characterized by flavonoid and polyphenol content, antioxidant activity, and genoprotective potential. The HCE3 extract, rich in catechins, quercetin, and epigallocatechin gallate, was selected for further analysis in three models: Eisenia fetida earthworms, SH-SY5Y neuron-like cells, and peripheral blood mononuclear cells (PBMCs) from PD patients. Results: The extracts showed antioxidant and genoprotective activity and contained flavonoid. No significant toxicity was observed in Eisenia fetida. In SH-SY5Y cells, GuaCa increased cell viability and brain-derived neurotrophic factor (BDNF) levels and reduced mitochondrial damage by lowering extracellular NDUSF7 (subunit of the NADH dehydrogenase (ubiquinone) complex) levels. In dPD-PBMCs cultures, GuaCa reduced pro-inflammatory cytokine IL-6 levels, indicating immunomodulatory effects. Conclusion: GuaCa shows promise as a nutraceutical for managing neuroinflammation and mitochondrial dysfunction in PD. Further clinical studies are needed to confirm GuaCa extract efficacy and potential for neuroprotective dietary strategies.
- Open Access
- 28 January 2025
- Published by MDPI AG in Preprints.org
Synergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson's Disease Management
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder linked to oxidative stress, mitochondrial dysfunction, and neuroinflammation. This study evaluates the neurofunctional and immunomodulatory effects of an aqueous extract combining cocoa seed husk and guarana powder (GuaCa). Eighteen extracts were characterized for flavonoid and polyphenol content, antioxidant activity, and genoprotective potential. The EQF3 extract, rich in catechins, quercetin, and epigallocatechin gallate, was selected for further analysis in three models: Eisenia fetida earthworms, SH-SY5Y neuron cells, and peripheral blood mononuclear cells (PBMCs) from PD patients. Results: The extracts showed antioxidant, genoprotective activity, and flavonoid content. No significant toxicity was observed in E. fetida. In SH-SY5Y cells, GuaCa increased cell viability and brain-derived neurotrophic factor (BDNF) levels and reduced mitochondrial damage by lowering extracellular NDUSF7 (subunit of the NADH dehydrogenase (ubiquinone) complex) levels. In PD-PBMCs cultures, GuaCa reduced pro-inflammatory cytokine IL-6 levels, indicating immunomodulatory effects. Conclusion: GuaCa shows promise as a nutraceutical for managing neuroinflammation and mitochondrial dysfunction in PD. Further clinical studies are needed to confirm its efficacy and potential for neuroprotective dietary strategies.
- 28 January 2025
- Published by MDPI AG in Preprints.org
Open AccessSynergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson's Disease Management
Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder linked to oxidative stress, mitochondrial dysfunction, and neuroinflammation. This study evaluates the neurofunctional and immunomodulatory effects of an aqueous extract combining cocoa seed husk and guarana powder (GuaCa). Eighteen extracts were characterized for flavonoid and polyphenol content, antioxidant activity, and genoprotective potential. The EQF3 extract, rich in catechins, quercetin, and epigallocatechin gallate, was selected for further analysis in three models: Eisenia fetida earthworms, SH-SY5Y neuron cells, and peripheral blood mononuclear cells (PBMCs) from PD patients. Results: The extracts showed antioxidant, genoprotective activity, and flavonoid content. No significant toxicity was observed in E. fetida. In SH-SY5Y cells, GuaCa increased cell viability and brain-derived neurotrophic factor (BDNF) levels and reduced mitochondrial damage by lowering extracellular NDUSF7 (subunit of the NADH dehydrogenase (ubiquinone) complex) levels. In PD-PBMCs cultures, GuaCa reduced pro-inflammatory cytokine IL-6 levels, indicating immunomodulatory effects. Conclusion: GuaCa shows promise as a nutraceutical for managing neuroinflammation and mitochondrial dysfunction in PD. Further clinical studies are needed to confirm its efficacy and potential for neuroprotective dietary strategies.
- Open Access
- 1 December 2023
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 16 (12) , 32178-32197
Does breast Cancer have a lower risk of mortality from Severe Acute Respiratory Syndrome compared to other types of Cancer? Evidence from Brazil, a heterogeneous population
To investigate the prevalence of hospitalizations and deaths related to severe acute respiratory syndrome in Brazilian women diagnosed with breast cancer. A 12-month retrospective study was performed using data from hospitalized women patients resulting from SARS-CoV-2 infection from a national database of acute respiratory lower disease notification forms (ARDL) between January 1 and December 2021. Data from non-pregnant and non-puerperium women> 18 years and with laboratory, COVID-19 diagnosis were selected and analyzed from 1048575 databank patients and categorized into three groups: without cancer diagnosis (WC), with breast cancer (BC), and with a diagnosis of other types of cancer (OC). OC was also sub-categorized in eight types of diagnosed cancer. Mortality and other clinical complications during the hospitalized period were compared between groups by analysis of variance followed by the post hoc Bonferroni test and the chi-square test. The influence of the following covariates was determined by multivariate logistic regression analysis: age, education, ethnicity, previous immunization to COVID-19, and presence of risk comorbidities. Brazilian BC had a lower risk of mortality from ARDL-COVID than those diagnosed OC patients. However, both groups presented a higher mortality risk than WC patients. Conclusions: These results are like some previous studies suggesting that BC lower risk could be a universal phenomenon independent of ethnicity and the presence of other risk comorbidities for COVID-19.
- 1 December 2023
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 16 (12) , 32178-32197
Open AccessDoes breast Cancer have a lower risk of mortality from Severe Acute Respiratory Syndrome compared to other types of Cancer? Evidence from Brazil, a heterogeneous population
To investigate the prevalence of hospitalizations and deaths related to severe acute respiratory syndrome in Brazilian women diagnosed with breast cancer. A 12-month retrospective study was performed using data from hospitalized women patients resulting from SARS-CoV-2 infection from a national database of acute respiratory lower disease notification forms (ARDL) between January 1 and December 2021. Data from non-pregnant and non-puerperium women> 18 years and with laboratory, COVID-19 diagnosis were selected and analyzed from 1048575 databank patients and categorized into three groups: without cancer diagnosis (WC), with breast cancer (BC), and with a diagnosis of other types of cancer (OC). OC was also sub-categorized in eight types of diagnosed cancer. Mortality and other clinical complications during the hospitalized period were compared between groups by analysis of variance followed by the post hoc Bonferroni test and the chi-square test. The influence of the following covariates was determined by multivariate logistic regression analysis: age, education, ethnicity, previous immunization to COVID-19, and presence of risk comorbidities. Brazilian BC had a lower risk of mortality from ARDL-COVID than those diagnosed OC patients. However, both groups presented a higher mortality risk than WC patients. Conclusions: These results are like some previous studies suggesting that BC lower risk could be a universal phenomenon independent of ethnicity and the presence of other risk comorbidities for COVID-19.